Clinical Trial Update: Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of naltrexone and ondansetron for alcoholism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• Ondansetron (ondansetron)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism | Phase 2 | Status: COMPLETED